Andreas Scorilas

17.6k total citations · 1 hit paper
429 papers, 13.8k citations indexed

About

Andreas Scorilas is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Andreas Scorilas has authored 429 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 251 papers in Molecular Biology, 131 papers in Genetics and 129 papers in Cancer Research. Recurrent topics in Andreas Scorilas's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (116 papers), Peptidase Inhibition and Analysis (66 papers) and MicroRNA in disease regulation (59 papers). Andreas Scorilas is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (116 papers), Peptidase Inhibition and Analysis (66 papers) and MicroRNA in disease regulation (59 papers). Andreas Scorilas collaborates with scholars based in Greece, Canada and United States. Andreas Scorilas's co-authors include Eleftherios P. Diamandis, Christos K. Kontos, George M. Yousef, Margaritis Avgeris, Maroulio Talieri, Hellinida Thomadaki, Konstantinos Mavridis, Panagiotis G. Adamopoulos, Alexandros Ardavanis and Iordanis N. Papadopoulos and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Andreas Scorilas

421 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

2022 158 citations Evangelos Terpos, Andreas Scorilas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Scorilas Greece	60	7.3k	3.9k	3.8k	3.6k	1.7k	429	13.8k
Gary E. Gallick United States	67	7.7k 1.1×	2.9k 0.7×	966 0.3×	6.0k 1.6×	1.2k 0.7×	202	13.7k
Hubert Serve Germany	59	8.5k 1.2×	2.9k 0.7×	2.6k 0.7×	3.1k 0.9×	6.8k 3.9×	299	15.5k
Ninette Amariglio Israel	66	12.1k 1.7×	4.1k 1.0×	1.4k 0.4×	2.4k 0.7×	1.4k 0.8×	266	17.9k
Joel S. Greenberger United States	68	7.7k 1.1×	1.7k 0.4×	2.8k 0.7×	3.1k 0.8×	2.4k 1.4×	447	18.6k
Carsten Müller‐Tidow Germany	64	11.4k 1.6×	4.3k 1.1×	1.8k 0.5×	4.3k 1.2×	5.3k 3.0×	492	18.0k
Ugo Testa Italy	68	8.7k 1.2×	2.7k 0.7×	2.3k 0.6×	3.0k 0.8×	4.9k 2.8×	423	16.9k
Andrew L. Kung United States	81	16.6k 2.3×	4.6k 1.2×	1.6k 0.4×	6.6k 1.8×	4.1k 2.4×	285	24.2k
C. Patrick Reynolds United States	74	12.7k 1.7×	4.8k 1.2×	1.4k 0.4×	5.0k 1.4×	935 0.5×	338	21.8k
Ruggero De Maria Italy	72	13.1k 1.8×	6.1k 1.5×	2.0k 0.5×	9.1k 2.5×	822 0.5×	257	22.8k
Jacqueline Whang‐Peng Taiwan	63	5.6k 0.8×	1.8k 0.4×	1.8k 0.5×	5.0k 1.4×	1.7k 1.0×	319	15.0k

Countries citing papers authored by Andreas Scorilas

Since Specialization

Citations

This map shows the geographic impact of Andreas Scorilas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Scorilas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Scorilas more than expected).

Fields of papers citing papers by Andreas Scorilas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Scorilas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Scorilas. The network helps show where Andreas Scorilas may publish in the future.

Co-authorship network of co-authors of Andreas Scorilas

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Scorilas. A scholar is included among the top collaborators of Andreas Scorilas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Scorilas. Andreas Scorilas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Papadimitriou, M., et al.. (2025). Loss of METTL3 m6A methyltransferase results in short‐term progression and poor treatment outcome of bladder cancer patients. International Journal of Cancer. 158(3). 763–774.

Athanasopoulou, Konstantina, et al.. (2025). Integrating Artificial Intelligence in Next-Generation Sequencing: Advances, Challenges, and Future Directions. Current Issues in Molecular Biology. 47(6). 470–470. 6 indexed citations

Papadimitriou, M., Konstantina Panoutsopoulou, Zoi Kanaki, et al.. (2024). CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients. SHILAP Revista de lepidopterología. 32(2). 200818–200818. 2 indexed citations

Kontos, Christos K., Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, et al.. (2024). ciRS‐7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. SHILAP Revista de lepidopterología. 5(4). 677–689. 3 indexed citations

Adamopoulos, Panagiotis G., Aikaterini Galani, Marios Kostakis, et al.. (2023). Spike-Seq: An amplicon-based high-throughput sequencing approach for the sensitive detection and characterization of SARS-CoV-2 genetic variations in environmental samples. The Science of The Total Environment. 914. 169747–169747. 1 indexed citations

Karousi, Paraskevi, Martina Samiotaki, Manousos Makridakis, et al.. (2023). 3′-tRF-CysGCA overexpression in HEK-293 cells alters the global expression profile and modulates cellular processes and pathways. Functional & Integrative Genomics. 23(4). 341–341. 2 indexed citations

Kontos, Christos K., Paraskevi Karousi, Pinelopi I. Artemaki, et al.. (2023). Novel circular RNAs of the apoptosis‐related BAX and BCL2L12 genes identified in a chronic lymphocytic leukemia cell line using nanopore sequencing. FEBS Open Bio. 13(10). 1953–1966. 2 indexed citations

Athanasopoulou, Konstantina, et al.. (2023). Recent Advances in Genome-Engineering Strategies. Genes. 14(1). 129–129. 20 indexed citations

Ji, Yuan, Konstantinos Stravodimos, Damo Xu, et al.. (2023). Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform. International Journal of Molecular Sciences. 24(11). 9258–9258. 4 indexed citations

10.

Adamopoulos, Panagiotis G., et al.. (2023). Unraveling the Concealed Transcriptomic Landscape of PTEN in HumanMalignancies. Current Genomics. 24(4). 250–262.

11.

Athanasopoulou, Konstantina, et al.. (2022). The Transition from Cancer “omics” to “epi-omics” through Next- and Third-Generation Sequencing. Life. 12(12). 2010–2010. 8 indexed citations

12.

Ράμπιας, Θεόδωρος, Dimitris Karagiannis, Margaritis Avgeris, et al.. (2019). The lysine‐specific methyltransferase KMT 2C/ MLL 3 regulates DNA repair components in cancer. EMBO Reports. 20(3). 96 indexed citations

13.

Khella, Heba, Andreas Scorilas, Roy Nofech‐Mozes, et al.. (2017). miR-10b is a prognostic marker in clear cell renal cell carcinoma. Journal of Clinical Pathology. 70(10). 854–859. 31 indexed citations

14.

Lamprianidou, Eleftheria, Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, et al.. (2015). The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine. Clinical Cancer Research. 22(8). 1958–1968. 16 indexed citations

15.

Vassilakopoulou, Maria, Margaritis Avgeris, Vamsidhar Velcheti, et al.. (2015). Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma. Clinical Cancer Research. 22(3). 704–713. 173 indexed citations

16.

Matsuzaki, Hiroumi, et al.. (2014). RAS/PI3K Crosstalk and Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 20(11). 2933–2946. 64 indexed citations

17.

Psyrri, Amanda, Sotirios G. Papageorgiou, Andreas Scorilas, et al.. (2009). Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma. Clinical Cancer Research. 15(18). 5724–5732. 86 indexed citations

18.

Zheng, Yingye, Dionyssios Katsaros, Shannon J.C. Shan, et al.. (2007). A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy. Clinical Cancer Research. 13(23). 6984–6992. 59 indexed citations

19.

Borgoño, Carla A., Antoninus Soosaipillai, Andreas Scorilas, et al.. (2003). Human kallikrein 5 (hK5): A hovel serum biomarker for ovarian and breast cancer.. mediaTUM (Technical University of Munich). 3 indexed citations

20.

Scorilas, Andreas, Angeliki Magklara, Melvin H. Thornton, et al.. (2001). Prostate-Specific Antigen and Human Glandular Kallikrein 2 Are Markedly Elevated in Urine of Patients with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 86(4). 1558–1561. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact